Clinical Trial Update: The Role of 5-Aminolevulinic Acid Fluorescence-Guided Surgery in Head and Neck Cancers: a Pilot Trial [Phase 2]

View source ↗

Summary

A terminated Phase 2 pilot trial investigated 5-ALA fluorescence-guided surgery for head and neck cancers, with results posted in 2025.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Skull Base Neoplasm

Drugs mentioned

• 5-ALA (5-aminolevulinic acid) (5-aminolevulinic acid)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Neoplasm, Skull Base Neoplasm | Phase 2 | Status: TERMINATED | Results posted: 2025-07-28